Research programme: magnetic particle imaging - Magnetic Insight/Stanford School of Medicine

Drug Profile

Research programme: magnetic particle imaging - Magnetic Insight/Stanford School of Medicine

Alternative Names: Magnetic particle imaging diagnostics

Latest Information Update: 30 Jun 2016

Price : $50

At a glance

  • Originator Magnetic Insight; Stanford University School of Medicine
  • Class Diagnostic agents
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Cancer; CNS disorders

Most Recent Events

  • 10 Mar 2016 Magnetic Insight and Stanford School of Medicine agree to co-develop magnetic particle imaging diagnostics in USA for Cancer and CNS disorders
  • 10 Mar 2016 Early research in CNS disorders (Diagnosis) in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top